Evidence map›Paper›PMID 23313748›Full record

ArticleThe American journal of pathology2013

Interaction of MCM7 and RACK1 for activation of MCM7 and cell growth.

Xi-Yue Zhang, Lang-Zhu Tang, Bao-Guo Ren, Yan P Yu, Joel Nelson, George Michalopoulos, Jian-Hua Luo

Open access · hybridAbstract read
In one paragraph

Article in The American journal of pathology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Repetitive magnetic stimulation promotes neural stem cells proliferation by upregulating MiR-106b in vitro.Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban · 2015
    Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Xi-Yue ZhangDepartment of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261, USA.
Lang-Zhu Tang
Bao-Guo Ren
Yan P Yu
Joel Nelson
George Michalopoulos
Jian-Hua Luo
University of Pittsburgh · US

Funding

University of Pittsburgh Clinical and Translational Science InstituteUL1TR000005 · NCATS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI REIS, STEVEN E · 2012 to 2015
$50.8M
The Role of Myopodin in Invasive Prostate CancersR01CA098249 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI LUO, JIANHUA · 2003 to 2014
$2.6M
Signaling of Integrin Alpha 7R56CA098249 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI LUO, JIANHUA · 2009 to 2009
$263k
NCATS NIH HHS UL1 TR000005NCI NIH HHS R01 CA098249NCI NIH HHS R56 CA098249
6 · The paper itself

Abstract

MCM7 is one of the pivotal DNA replication licensing factors in controlling DNA synthesis and cell entry into S phase. Its expression and DNA copy number are some of the most predictive factors for the growth and behavior of human malignancies. In this study, we identified that MCM7 interacts with the receptor for activated protein kinase C 1 (RACK1), a protein kinase C (PKC) adaptor, in vivo and in vitro. The RACK1 binding motif in MCM7 is located at the amino acid 221-248. Knocking down RACK1 significantly reduced MCM7 chromatin association, DNA synthesis, and cell cycle entry into S phase. Activation of PKC by 12-O-tetradecanoylphorbol-13-acetate dramatically decreased MCM7 DNA replication licensing and induced cell growth arrest. Activation of PKC induced redistribution of RACK1 from nucleus to cytoplasm and decreased RACK1-chromatin association. The MCM7 mutant that does not bind RACK1 has no DNA replication licensing or oncogenic transformation activity. As a result, this study demonstrates a novel signaling mechanism that critically controls DNA synthesis and cell cycle progression.

Indexed as

Cell Cycle ProteinsCell Line, TumorCell ProliferationCell Transformation, NeoplasticChromatinDNADNA-Binding ProteinsEnzyme ActivationGTP-Binding ProteinsHumansMinichromosome Maintenance Complex Component 7Models, BiologicalNeoplasm ProteinsNuclear ProteinsProtein BindingProtein Kinase CCell Cycle ProteinsChromatinDNADNA-Binding ProteinsGTP-Binding ProteinsMCM7 protein, humanMinichromosome Maintenance Complex Component 7Neoplasm ProteinsNuclear ProteinsProtein Kinase CRACK1 protein, humanReceptors, Cell SurfaceReceptors for Activated C Kinase

Identifiers

PMID23313748
PMCPMC3586685
OpenAlexW2021110394

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.